Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that NILA, the native utility and governance token of the MindChain network developed by its wholly owned subsidiary, MindWave Innovations Inc. USA, is scheduled to begin trading on the Pionex cryptocurrency exchange on Oct. 14, 2026, at 6 a.m. Eastern time. The listing will make NILA available to eligible users through the NILA/USDT trading pair, with access to Pionex's standard trading features and automated trading tools. This development is significant because it represents a major step in expanding international access to NILA ahead of its planned migration to MindChain, an Ethereum-based Layer 2 network designed to support enterprise blockchain applications.
The listing on Pionex, a global cryptocurrency exchange, is expected to increase liquidity and visibility for NILA, potentially attracting a broader base of users and investors. MindWave has recently signed agreements to develop three dedicated networks — AQUAEChain, FlashChain and AssureChain — on MindChain. Following the network's launch, NILA is designed to support transaction fees, staking and network security, subject to applicable regulatory and technical requirements. These developments underscore the company's commitment to building a robust enterprise blockchain infrastructure.
For stakeholders, the Pionex listing could enhance the token's utility and adoption, as it becomes more accessible to a global audience. The migration to MindChain is a critical phase, as it aims to provide a scalable and secure environment for enterprise applications. MindWave Innovations Inc. USA focuses on developing enterprise blockchain infrastructure, the MindChain Layer 2 network, and institutional platforms for regulated financial services, real-world asset tokenization and enterprise applications. The company's efforts are further supported by MindWaveDAO, the community and ecosystem layer around MindChain, which connects companies, builders, validators and token holders.
NILA holders have governance rights, voting on proposals including which builders are funded, which programs launch and how ecosystem resources are allocated. The Transparency Center publishes contributions, allocations and governance results, ensuring accountability. This governance model empowers the community and aligns with the broader trend of decentralized decision-making in blockchain projects.
The announcement was disseminated through TechMediaWire, a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. TechMediaWire is part of the Dynamic Brand Portfolio at IBN, which delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries. The platform also offers article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, and social media distribution via IBN to millions of social media followers.
For investors, the latest news and updates relating to APUS are available in the company's newsroom at https://ibn.fm/APUS. The full press release can be viewed at https://ibn.fm/Hv464. As the blockchain landscape evolves, Apimeds Pharmaceuticals' strategic moves with MindWave and NILA position it to potentially capitalize on the growing demand for enterprise blockchain solutions and digital asset services.
